These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12436221

  • 1. Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.
    Grunberg SM, Srivastava A, Grunberg KJ, Weeks J.
    Support Care Cancer; 2002 Nov; 10(8):624-9. PubMed ID: 12436221
    [Abstract] [Full Text] [Related]

  • 2. The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models.
    Shelke AR, Mustian KM, Morrow GR.
    Indian J Physiol Pharmacol; 2004 Jul; 48(3):256-68. PubMed ID: 15648398
    [Abstract] [Full Text] [Related]

  • 3. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients.
    Raghavendra RM, Nagarathna R, Nagendra HR, Gopinath KS, Srinath BS, Ravi BD, Patil S, Ramesh BS, Nalini R.
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):462-74. PubMed ID: 17944760
    [Abstract] [Full Text] [Related]

  • 4. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [Abstract] [Full Text] [Related]

  • 5. Symptom experiences during chemotherapy treatment--with focus on nausea and vomiting.
    Bergkvist K, Wengström Y.
    Eur J Oncol Nurs; 2006 Feb; 10(1):21-9. PubMed ID: 15908274
    [Abstract] [Full Text] [Related]

  • 6. Measuring chemotherapy-induced nausea and emesis.
    Martin CG, Rubenstein EB, Elting LS, Kim YJ, Osoba D.
    Cancer; 2003 Aug 01; 98(3):645-55. PubMed ID: 12879484
    [Abstract] [Full Text] [Related]

  • 7. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J.
    J Clin Oncol; 2006 Sep 20; 24(27):4472-8. PubMed ID: 16983116
    [Abstract] [Full Text] [Related]

  • 8. Nausea and vomiting and cancer patients' quality of life: a discussion of Professor Selby's paper.
    Lindley CM, Hirsch JD.
    Br J Cancer Suppl; 1992 Dec 20; 19():S26-9. PubMed ID: 1467197
    [Abstract] [Full Text] [Related]

  • 9. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS, Kymes SM, Nease RF, Sumner W, Siegfried CJ, Gordon MO.
    Ophthalmology; 2008 May 20; 115(5):898-903.e4. PubMed ID: 17826833
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J, Birch S, Slee C, McCarthy TJ, Helms LJ, Kuppermann M.
    Med Care; 2008 Sep 20; 46(9):946-53. PubMed ID: 18725849
    [Abstract] [Full Text] [Related]

  • 11. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
    Dibble SL, Luce J, Cooper BA, Israel J, Cohen M, Nussey B, Rugo H.
    Oncol Nurs Forum; 2007 Jul 20; 34(4):813-20. PubMed ID: 17723973
    [Abstract] [Full Text] [Related]

  • 12. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct 20; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 13. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I, Coast J, Brown J.
    Pediatrics; 2005 May 20; 115(5):e600-14. PubMed ID: 15867026
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
    López-Jiménez J, Martín-Ballesteros E, Sureda A, Uralburu C, Lorenzo I, del Campo R, Fernández C, Calbacho M, García-Belmonte D, Fernández G.
    Haematologica; 2006 Jan 20; 91(1):84-91. PubMed ID: 16434375
    [Abstract] [Full Text] [Related]

  • 15. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ.
    Cancer; 2003 May 01; 97(9):2290-300. PubMed ID: 12712486
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE.
    J Support Oncol; 2007 May 01; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Common toxicities of cancer chemotherapy.
    Khoo KS, Ang PT, Lim AG.
    Singapore Med J; 1993 Oct 01; 34(5):418-20. PubMed ID: 8153689
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.